RBC Capital reiterated coverage on ATAI Life Sciences with a new price target

11/16/21 7:03:06 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

RBC Capital reiterated coverage of ATAI Life Sciences with a rating of Sector Perform and set a new price target of $17.00 from $19.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ATAI

Date	Price Target	Rating	Analyst
4/4/2025		Buy	Berenberg
11/18/2024	$15.00 → $10.00	Buy	H.C. Wainwright
4/3/2024	$6.00	Hold → Buy	Maxim Group
11/1/2022	$18.00	Buy	Loop Capital
11/30/2021	$25.00	Buy	Maxim Group
11/22/2021	$40.00 → $50.00	Buy	HC Wainwright & Co.
11/16/2021	$25.00 → $24.00	Outperform	Credit Suisse
11/16/2021	$19.00 → $17.00	Sector Perform	RBC Capital